Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key
- PMID: 39346921
- PMCID: PMC11437524
- DOI: 10.3389/fimmu.2024.1456636
Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key
Abstract
The dependence of tumor cells on glycolysis provides essential energy and raw materials for their survival and growth. Recent research findings have indicated that long chain non-coding RNAs (LncRNAs) have a key regulatory function in the tumor glycolytic pathway and offer new opportunities for cancer therapy. LncRNAs are analogous to a regulatory key during glycolysis. In this paper, we review the mechanisms of LncRNA in the tumor glycolytic pathway and their potential therapeutic strategies, including current alterations in cancer-related energy metabolism with lncRNA mediating the expression of key enzymes, lactate production and transport, and the mechanism of interaction with transcription factors, miRNAs, and other molecules. Studies targeting LncRNA-regulated tumor glycolytic pathways also offer the possibility of developing new therapeutic strategies. By regulating LncRNA expression, the metabolic pathways of tumor cells can be interfered with to inhibit tumor growth and metastasis, thus affecting the immune and drug resistance mechanisms of tumor cells. In addition, lncRNAs have the capacity to function as molecular markers and target therapies, thereby contributing novel strategies and approaches to the field of personalized cancer therapy and prognosis evaluation. In conclusion, LncRNA, as key molecules regulating the tumor glycolysis pathway, reveals a new mechanism of abnormal metabolism in cancer cells. Future research will more thoroughly investigate the specific mechanisms of LncRNA glycolysis regulation and develop corresponding therapeutic strategies, thereby fostering new optimism for the realization of precision medicine.
Keywords: cancer; glycolysis; immune; lncRNA; metabolism.
Copyright © 2024 Zhang, Zhang, Liu, Zeng and Song.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer.Int J Mol Sci. 2020 Apr 22;21(8):2947. doi: 10.3390/ijms21082947. Int J Mol Sci. 2020. PMID: 32331347 Free PMC article. Review.
-
Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.BMC Med Genomics. 2020 Mar 30;13(1):57. doi: 10.1186/s12920-020-0707-0. BMC Med Genomics. 2020. PMID: 32228580 Free PMC article.
-
Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.Funct Integr Genomics. 2022 Aug;22(4):597-609. doi: 10.1007/s10142-022-00845-9. Epub 2022 Apr 14. Funct Integr Genomics. 2022. PMID: 35420332
-
Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment.BMC Med. 2021 Feb 25;19(1):59. doi: 10.1186/s12916-021-01925-6. BMC Med. 2021. PMID: 33627136 Free PMC article.
-
LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.Front Immunol. 2024 Oct 30;15:1467151. doi: 10.3389/fimmu.2024.1467151. eCollection 2024. Front Immunol. 2024. PMID: 39539540 Free PMC article. Review.
Cited by
-
"Friends or foes": a new perspective of tumour metabolic transcriptional modification.Cell Death Dis. 2025 Feb 17;16(1):106. doi: 10.1038/s41419-025-07429-y. Cell Death Dis. 2025. PMID: 39962057 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical